SPIRO[3H-INDOLE-3,2 -PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
wherein the groups R1 to R4, R7, A, D, E, F, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; lit |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KERRES, Nina HUCHLER, Guenther GOEPPER, Stefan GILLE, Annika BROEKER, Joachim KOFINK, Christiane WEINSTABL, Harald HENRY, Manuel GOLLNER, Andreas RAMHARTER, Juergen |
description | wherein the groups R1 to R4, R7, A, D, E, F, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LT3359542TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LT3359542TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LT3359542TT3</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEuDqK-w40K3mBiBsfaRHLQ5kISC1KkFImTaKG-Pzr4AE4_H_zzooueAnfSIjnNtUG5FYD-EgLXpMldUax3doPsDFTceD47HaF0GrQJ1JaJWvN1hEY3Ar2SQM7SkRKHuCxm9-Ex5dWviwJOJlUW8_jq8zQOt_zM775OUqqD2ouU5B_LB83YMXY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SPIRO[3H-INDOLE-3,2 -PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS</title><source>esp@cenet</source><creator>KERRES, Nina ; HUCHLER, Guenther ; GOEPPER, Stefan ; GILLE, Annika ; BROEKER, Joachim ; KOFINK, Christiane ; WEINSTABL, Harald ; HENRY, Manuel ; GOLLNER, Andreas ; RAMHARTER, Juergen</creator><creatorcontrib>KERRES, Nina ; HUCHLER, Guenther ; GOEPPER, Stefan ; GILLE, Annika ; BROEKER, Joachim ; KOFINK, Christiane ; WEINSTABL, Harald ; HENRY, Manuel ; GOLLNER, Andreas ; RAMHARTER, Juergen</creatorcontrib><description>wherein the groups R1 to R4, R7, A, D, E, F, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.</description><language>eng ; lit</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210525&DB=EPODOC&CC=LT&NR=3359542T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210525&DB=EPODOC&CC=LT&NR=3359542T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KERRES, Nina</creatorcontrib><creatorcontrib>HUCHLER, Guenther</creatorcontrib><creatorcontrib>GOEPPER, Stefan</creatorcontrib><creatorcontrib>GILLE, Annika</creatorcontrib><creatorcontrib>BROEKER, Joachim</creatorcontrib><creatorcontrib>KOFINK, Christiane</creatorcontrib><creatorcontrib>WEINSTABL, Harald</creatorcontrib><creatorcontrib>HENRY, Manuel</creatorcontrib><creatorcontrib>GOLLNER, Andreas</creatorcontrib><creatorcontrib>RAMHARTER, Juergen</creatorcontrib><title>SPIRO[3H-INDOLE-3,2 -PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS</title><description>wherein the groups R1 to R4, R7, A, D, E, F, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEuDqK-w40K3mBiBsfaRHLQ5kISC1KkFImTaKG-Pzr4AE4_H_zzooueAnfSIjnNtUG5FYD-EgLXpMldUax3doPsDFTceD47HaF0GrQJ1JaJWvN1hEY3Ar2SQM7SkRKHuCxm9-Ex5dWviwJOJlUW8_jq8zQOt_zM775OUqqD2ouU5B_LB83YMXY</recordid><startdate>20210525</startdate><enddate>20210525</enddate><creator>KERRES, Nina</creator><creator>HUCHLER, Guenther</creator><creator>GOEPPER, Stefan</creator><creator>GILLE, Annika</creator><creator>BROEKER, Joachim</creator><creator>KOFINK, Christiane</creator><creator>WEINSTABL, Harald</creator><creator>HENRY, Manuel</creator><creator>GOLLNER, Andreas</creator><creator>RAMHARTER, Juergen</creator><scope>EVB</scope></search><sort><creationdate>20210525</creationdate><title>SPIRO[3H-INDOLE-3,2 -PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS</title><author>KERRES, Nina ; HUCHLER, Guenther ; GOEPPER, Stefan ; GILLE, Annika ; BROEKER, Joachim ; KOFINK, Christiane ; WEINSTABL, Harald ; HENRY, Manuel ; GOLLNER, Andreas ; RAMHARTER, Juergen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LT3359542TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; lit</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KERRES, Nina</creatorcontrib><creatorcontrib>HUCHLER, Guenther</creatorcontrib><creatorcontrib>GOEPPER, Stefan</creatorcontrib><creatorcontrib>GILLE, Annika</creatorcontrib><creatorcontrib>BROEKER, Joachim</creatorcontrib><creatorcontrib>KOFINK, Christiane</creatorcontrib><creatorcontrib>WEINSTABL, Harald</creatorcontrib><creatorcontrib>HENRY, Manuel</creatorcontrib><creatorcontrib>GOLLNER, Andreas</creatorcontrib><creatorcontrib>RAMHARTER, Juergen</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KERRES, Nina</au><au>HUCHLER, Guenther</au><au>GOEPPER, Stefan</au><au>GILLE, Annika</au><au>BROEKER, Joachim</au><au>KOFINK, Christiane</au><au>WEINSTABL, Harald</au><au>HENRY, Manuel</au><au>GOLLNER, Andreas</au><au>RAMHARTER, Juergen</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SPIRO[3H-INDOLE-3,2 -PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS</title><date>2021-05-25</date><risdate>2021</risdate><abstract>wherein the groups R1 to R4, R7, A, D, E, F, V, W, X, Y, n, r and q are defined in claim 1, their use as inhibitors of MDM2-p53 interaction, pharmaceutical compositions which contain compounds of this kind, their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases, and synthetic intermediates.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; lit |
recordid | cdi_epo_espacenet_LT3359542TT |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | SPIRO[3H-INDOLE-3,2 -PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A26%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KERRES,%20Nina&rft.date=2021-05-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELT3359542TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |